Mednet Logo
HomeOphthalmology
Ophthalmology

Ophthalmology

Expert insights on ocular conditions, surgical techniques, retinal disease, and vision-related management.

Recent Discussions

How do you account for tumor growth from pre-operative to intra-operative ultrasound for uveal melanoma?

2 Answers

Mednet Member
Mednet Member
Radiation Oncology · Penn State Milton S Hershey Medical Center

On B scan, measure the thickness from apex AP and also do basal measurements. Base measurements are done through indirect ophthalmoscope also. At each visit, pre-op and postop, both B scan measurements (for tumor thickness) are done and also indirect ophthalmoscope measurements. My twin sister is an...

How would you approach a symptomatic patient with with a history of whole brain RT with new bilateral MRI enhancing lesions within the optic nerves?

1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Varian Medical Systems/Allegheny health network

The differential would be optic neuritis from immunotherapy or leptomeningeal disease. Is there any visual deficit? It appears there is a lesion as described above rather than enhancement which would favor disease. One would need to know the disease status outside brain and if there is any other sus...

What would you recommend for a patient with bilateral conjunctival MALT (without systemic disease)?

1
1 Answers

Mednet Member
Mednet Member
Radiation Oncology · University of Colorado School of Medicine

While technically this patient is stage IVAE (>1 extranodal site is categorized as stage IV), these patients do as well as those with unilateral conjunctival MALT NHL. Bilaterality is not unusual in this disease. This is a situation where definitive treatment (24 Gy in 12) is appropriate for stage I...

Should regular screening brain MRIs be done for children with germline RB1 mutation in addition to eye exams?

1 Answers

Mednet Member
Mednet Member
Pediatric Hematology/Oncology · Logan Health Medical Center

Yes, baseline brain MRI and routine screening approximately every 6 months until the age of 5 years is recommended in any heritable RB patient, including those with bilateral disease or unilateral disease with a family history of the disease (to account for those individuals who may not have an "ide...

Do you extrapolate from uveitis treatment pathways when managing other inflammatory eye conditions such as atypical serpiginous choroiditis?

2 Answers

Mednet Member
Mednet Member
Ophthalmology · Northwestern

I do tend to apply these principles. So these entities like serpiginous, relentless placoid, etc., I would consider posterior uveitis. While we definitely do not fully understand the full pathophysiology of all these diseases, there is good evidence of inflammatory activity, hence response to steroi...

What do you use to treat uveitis refractory to conventional synthetic DMARDs and TNF inhibitors?

5 Answers

Mednet Member
Mednet Member
Ophthalmology · University of Wisconsin School of Medicine and Public Health

I would add support to a trial of intravenous tocilizumab, particularly if macular edema is a feature of the uveitis. The STOP-Uveitis trial demonstrated reasonable efficacy in intermediate, posterior, and panuveitis (STOP-Uveitis) and I have used this within my own practice with success in patients...

Is there a role for radiation therapy in the treatment of a lymphoproliferative disorder involving the orbit?

2
4 Answers

Mednet Member
Mednet Member
Radiation Oncology · Duke University Medical Center

The great majority of lymphoproliferative disorders of the orbit turn out to be NHL when subjected to sophisticated pathologic evaluation, but even those which are considered benign lymphoid hyperplasia (LH) are often and successfully treated with radiotherapy. The dose of RT for low-grade lymphoma ...

How long do you continue steroid-sparing agents such as tocilizumab for GCA once the disease is in remission off steroids?

5
1 Answers

Mednet Member
Mednet Member
Rheumatology · Director, Vasculitis Clinical Research Consortium

This is an excellent question and one we confront regularly. This is another of what I call “happy problems” because it is a consequence of increasing options for effective therapy for our patients.Tocilizumab is clearly an effective agent for some patients with giant cell arteritis (GCA), and patie...

How do you manage MEK inhibitor induced ocular adverse events?

1
1 Answers

Mednet Member
Mednet Member
Medical Oncology · Emory University School of Medicine

MEK inhibitor associated ocular adverse events may range from subretinal fluid, which does not typically require medication cessation to uveitis, which is treated according to the level of inflammation. In one report of optical coherence tomography scan evaluations to image retinal structures follow...

Are there any situations in which you would consider starting steroid-sparing agents at the outset for patients with scleritis without any evidence of systemic rheumatic disease?

2 Answers

Mednet Member
Mednet Member
Ophthalmology · Northwestern

Great question. I agree with Dr. @Dr. First Last that if the disease is very severe and we cannot risk flaring or continued activity I would consider it, or with contraindications to steroids. If this is not the case, I would try to treat acutely with NSAID or steroid, and if the disease keeps flari...